John W. Davies

63 year

Consumer Services

Health Technology

Commercial Services

Profile

John W.
Davies worked as the Global Head-Silico Lead Discovery at Novartis Institutes for Biomedical Research, Inc. from 2012 to 2017.
He then worked as the Chief Technology Officer at Kaleido Biosciences, Inc. from 2017 to 2019.
Prior to his professional career, he earned an undergraduate degree from the University of East London and a doctorate from University College London.

Former positions of John W. Davies

Companies	Position	End
KALEIDO BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	31/12/2018
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	31/12/2016

See the detail of John W. Davies's experience

Training of John W. Davies

University of East London	Undergraduate Degree
University College London	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John W. Davies's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
KALEIDO BIOSCIENCES, INC.	Health Technology

Private companies	1
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.	Commercial Services